Lloyd A. Rowland - 18 Mar 2025 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
General Counsel
Signature
/s/ Lloyd Rowland
Issuer symbol
CTMX
Transactions as of
18 Mar 2025
Net transactions value
-$6,112
Form type
4
Filing time
20 Mar 2025, 16:32:22 UTC
Previous filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $6,112 -10,203 -7.8% $0.5990 120,594 18 Mar 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Includes 30,624 RSUs.